Patient and Provider Perspectives on Symptom Monitoring During Outpatient Chemotherapy: Interview Study

por Chen, Leeann, Bartel, Christianna, Cai, Xinlu, Cheng, Yanghuidi, Perer, Adam, McClaine, Sean, Kairis, Elizabeth, Durica, Krina, Huang, Weiyu, Low, Carissa A
Publicado 2023

5-methylcytosine (m(5)C) RNA modification controls the innate immune response to virus infection by regulating type I interferons

por Zhang, Yuexiu, Zhang, Li-Sheng, Dai, Qing, Chen, Phylip, Lu, Mijia, Kairis, Elizabeth L., Murugaiah, Valarmathy, Xu, Jiayu, Shukla, Rajni Kant, Liang, Xueya, Zou, Zhongyu, Cormet-Boyaka, Estelle, Qiu, Jianming, Peeples, Mark E., Sharma, Amit, He, Chuan, Li, Jianrong
Publicado 2022

Viral RNA N(6)-methyladenosine modification modulates both innate and adaptive immune responses of human respiratory syncytial virus

por Xue, Miaoge, Zhang, Yuexiu, Wang, Haitao, Kairis, Elizabeth L., Lu, Mijia, Ahmad, Sadeem, Attia, Zayed, Harder, Olivia, Zhang, Zijie, Wei, Jiangbo, Chen, Phylip, Gao, Youling, Peeples, Mark E., Sharma, Amit, Boyaka, Prosper, He, Chuan, Hur, Sun, Niewiesk, Stefan, Li, Jianrong
Publicado 2021